In the midst of a volatile U.S. stock market, where major indices like the Dow Jones and S&P 500 are experiencing fluctuations due to impending tariff announcements, investors are closely watching for opportunities that align with current economic conditions. One strategy gaining attention is investing in growth companies with high insider ownership, as these stocks often indicate strong confidence from those who know the business best and can potentially provide resilience amid market uncertainties.
Top 10 Growth Companies With High Insider Ownership In The United States
Overview: Byrna Technologies Inc. is a less-lethal self-defense technology company that develops, manufactures, and sells personal security solutions across various global markets, with a market cap of $381.37 million.
Operations: Byrna's revenue is primarily derived from its Aerospace & Defense segment, which generated $85.76 million.
Insider Ownership: 20.8%
Revenue Growth Forecast: 23.2% p.a.
Byrna Technologies, recently added to the S&P Aerospace & Defense Select Industry Index, is experiencing strong growth with earnings forecasted to grow at 17.2% annually and revenue at 23.2%, both surpassing market averages. Despite high insider ownership, recent months saw significant insider selling rather than buying. The company has expanded its U.S.-based manufacturing capabilities and formed strategic partnerships, such as with Sportsman’s Warehouse, enhancing its market presence and operational efficiency in the less-lethal defense sector.
Overview: USA Rare Earth, Inc. is involved in the mining, processing, and supply of rare earths and other critical minerals with a market cap of $486.80 million.
Operations: The company does not have specific revenue segments detailed in the provided text.
Insider Ownership: 17.1%
Revenue Growth Forecast: 46.4% p.a.
USA Rare Earth is advancing its position in the rare earth magnet sector with its newly commissioned Innovations Lab in Oklahoma, aimed at enhancing R&D and production capabilities. Despite high insider ownership and projected revenue growth of 46.4% annually, the company faces challenges like recent auditor doubts about its going concern status and past shareholder dilution. The company's strategic focus on domestic supply chain strengthening could mitigate reliance on international markets, especially as it prepares for future profitability within three years.
Overview: Alphatec Holdings, Inc. is a medical technology company that focuses on designing and developing technologies for the surgical treatment of spinal disorders, with a market cap of approximately $1.46 billion.
Operations: The company's revenue primarily comes from its Medical Products segment, which generated $611.56 million.
Insider Ownership: 12.1%
Revenue Growth Forecast: 14.1% p.a.
Alphatec Holdings is trading significantly below its estimated fair value and shows promising growth potential, with forecasted earnings expected to grow 53.25% annually. Despite reporting a net loss of US$33.33 million for Q4 2024, the company has improved from the previous year's loss and anticipates a revenue increase to US$732 million in 2025, marking approximately 20% growth from 2024. Recent $350 million fixed-income offerings could support strategic initiatives as it aims for profitability within three years.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.The analysis only considers stock directly held by insiders. It does not include indirectly owned stock through other vehicles such as corporate and/or trust entities. All forecast revenue and earnings growth rates quoted are in terms of annualised (per annum) growth rates over 1-3 years.
